Centogene

What They Do

Rare disease diagnostics and multiomic data platform leveraging AI for genetic insights. Maintains one of the world's largest rare disease datasets.

Funding

Valuation: Sold operating assets for €8.7M (2025); was Nasdaq-listed Publicly listed (Nasdaq: CNTG)

See Also

• Germany
• Rare Disease